iii) mTORC1/2 inhibitors suppressed R2TNF-mediated induction of pSer65-4EBP1 expression in correlation with their potency at inhibiting cell cycle entry, and increased tumor cell death. The gene discussed is TNFRSF1B; the disease is neoplasm.